Rating Change
RBC Capital reiterated its Sector Perform rating on EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) on October 20, 2026.
reiterateNASDAQ:EYPT
RBC Capital Reiterates Sector Perform Rating on EyePoint Pharmaceuticals, Inc. (EYPT)
RBC Capital reiterated its Sector Perform rating on EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) on October 20, 2026.
At publication ·
What changed
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) · reiterate
- Firm
- RBC Capital
- Rating
- Sector Perform to Sector Perform
- Price at event
- $0.43
- Market capitalization
- $1.1B
At a glance
Key takeaways
- EyePoint Pharmaceuticals stock has declined 74.5% over the past 52 weeks and currently trades at $0.43 with a $1.1B market capitalization.
Market Context
EyePoint Pharmaceuticals, Inc. operates in the Healthcare sector. The stock currently trades at $0.43 with a market capitalization of $1.1B. The stock has declined 74.5% over the past 52 weeks.
Analyst coverage from RBC Capital provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for EyePoint Pharmaceuticals, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for EyePoint Pharmaceuticals, Inc.
Among the 10 most recent ratings: 2 Buy, 7 Hold, 1 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 20, 2026 | JP Morgan | Underweight | N/A |
| Oct 20, 2026 | RBC Capital | Sector Perform | N/A |
| Oct 20, 2026 | Guggenheim | Neutral | N/A |
| Oct 20, 2026 | HC Wainwright & Co. | Neutral | N/A |
| Sep 02, 2026 | TD Cowen | Hold | N/A |
Related Tools: Analyst Ratings Dashboard | View EYPT Stock Page
Frequently Asked Questions
What does the Sector Perform rating mean for EYPT?
A rating of Sector Perform from RBC Capital reflects the analyst's outlook on EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the EYPT forecast page.